Mylan Institutional LLC Recalls One Lot of Octreotide Acetate Injection, 500 mcg/mL Because the Syringe Contains Glass Particulates
Mylan Institutional LLC, a Viatris Company, has issued a voluntary recall of one lot of its Octreotide Acetate Injection AJ21002, exp 3/2024 due to the presence of glass particulates in the syringe. The 500 mcg/mL strength is packed in a carton containing ten 1ml syringes and was distributed nationwide in the U.S. to wholesalers/distributors (including […]